TN2014000518A1 - Reassortant btv and ahsv vaccines - Google Patents
Reassortant btv and ahsv vaccinesInfo
- Publication number
- TN2014000518A1 TN2014000518A1 TN2014000518A TN2014000518A TN2014000518A1 TN 2014000518 A1 TN2014000518 A1 TN 2014000518A1 TN 2014000518 A TN2014000518 A TN 2014000518A TN 2014000518 A TN2014000518 A TN 2014000518A TN 2014000518 A1 TN2014000518 A1 TN 2014000518A1
- Authority
- TN
- Tunisia
- Prior art keywords
- vaccines
- btv
- ahsv
- ashv
- reassortant
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000134897 Arctic ground squirrel hepatitis B virus Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659198P | 2012-06-13 | 2012-06-13 | |
| PCT/US2013/045667 WO2013188673A2 (en) | 2012-06-13 | 2013-06-13 | Reassortant btv and ahsv vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2014000518A1 true TN2014000518A1 (en) | 2016-03-30 |
Family
ID=49237584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2014000518A TN2014000518A1 (en) | 2012-06-13 | 2014-12-12 | Reassortant btv and ahsv vaccines |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10801039B2 (https=) |
| EP (1) | EP2861248B1 (https=) |
| JP (1) | JP6347257B2 (https=) |
| KR (1) | KR102136437B1 (https=) |
| CN (2) | CN110628822A (https=) |
| AU (2) | AU2013274191B2 (https=) |
| BR (1) | BR112014031133B1 (https=) |
| CA (1) | CA2876196C (https=) |
| ES (1) | ES2664069T3 (https=) |
| IL (1) | IL236148B (https=) |
| MA (1) | MA37749B1 (https=) |
| MX (1) | MX364875B (https=) |
| NZ (1) | NZ703297A (https=) |
| RU (1) | RU2656187C2 (https=) |
| TN (1) | TN2014000518A1 (https=) |
| WO (1) | WO2013188673A2 (https=) |
| ZA (1) | ZA201409124B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11053509B2 (en) | 2016-04-19 | 2021-07-06 | Csir | Plant-produced chimaeric Orbivirus VLPs |
| AU2017256071B2 (en) * | 2016-04-26 | 2022-11-17 | London School Of Hygiene & Tropical Medicine | Reoviridae vaccine |
| WO2018103038A1 (zh) * | 2016-12-08 | 2018-06-14 | 拜西欧斯（北京）生物技术有限公司 | 一种缀合物及其应用 |
| CN109897092B (zh) * | 2019-04-02 | 2019-11-19 | 深圳海关动植物检验检疫技术中心 | 一种蓝舌病病毒非结构蛋白ns3的可溶制备方法 |
| CN110016466B (zh) * | 2019-05-21 | 2022-09-13 | 云南省畜牧兽医科学院 | 特异性检测蓝舌病病毒的单抗及其杂交瘤细胞株和应用 |
| CN110257560B (zh) * | 2019-07-23 | 2023-06-27 | 深圳海关动植物检验检疫技术中心 | 一种用于蓝舌病病毒8型检测的试剂、检测方法及应用 |
| CN112375848A (zh) * | 2020-12-11 | 2021-02-19 | 云南省畜牧兽医科学院 | 一种蓝舌病病毒血清型鉴定的RT-qPCR检测试剂盒和方法 |
| CN116024183B (zh) * | 2023-02-15 | 2023-10-31 | 中国农业科学院兰州兽医研究所 | 一种用于荧光染色的重组蓝舌病毒及其构建方法 |
| CN120271699B (zh) * | 2025-04-10 | 2026-03-31 | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 一株特异识别蓝舌病毒vp5蛋白的单克隆抗体 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| AU613316B2 (en) | 1986-09-12 | 1991-08-01 | Genentech Inc. | Improved recombinant expression |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
| DE69233158T2 (de) | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
| JPH11504631A (ja) | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Ｄｎａ／脂質複合体の単一バイアル製剤 |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
| FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
| FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
| FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
| FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
| FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| AU8444798A (en) | 1997-06-30 | 1999-01-25 | Centre National De La Recherche Scientifique | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
| FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| US7371395B2 (en) | 2003-07-24 | 2008-05-13 | Merial Limited | Vaccine formulations |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| EP2062594A1 (en) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| JP5619614B2 (ja) * | 2007-11-26 | 2014-11-05 | ロンドン スクール オブ ハイジーン アンド トロピカル メディシンＬｏｎｄｏｎ Ｓｃｈｏｏｌ Ｏｆ Ｈｙｇｉｅｎｅ ＆ Ｔｒｏｐｉｃａｌ Ｍｅｄｉｃｉｎｅ | レオウイルス科のウイルスのワクチン用ウイルス株を製造する方法 |
-
2013
- 2013-06-13 EP EP13766730.9A patent/EP2861248B1/en active Active
- 2013-06-13 RU RU2015100269A patent/RU2656187C2/ru active
- 2013-06-13 JP JP2015517428A patent/JP6347257B2/ja active Active
- 2013-06-13 US US13/917,259 patent/US10801039B2/en active Active
- 2013-06-13 CN CN201910804847.8A patent/CN110628822A/zh active Pending
- 2013-06-13 CA CA2876196A patent/CA2876196C/en active Active
- 2013-06-13 MA MA37749A patent/MA37749B1/fr unknown
- 2013-06-13 CN CN201380038286.6A patent/CN104582724A/zh active Pending
- 2013-06-13 KR KR1020157000827A patent/KR102136437B1/ko active Active
- 2013-06-13 AU AU2013274191A patent/AU2013274191B2/en active Active
- 2013-06-13 WO PCT/US2013/045667 patent/WO2013188673A2/en not_active Ceased
- 2013-06-13 NZ NZ703297A patent/NZ703297A/en unknown
- 2013-06-13 MX MX2014015311A patent/MX364875B/es active IP Right Grant
- 2013-06-13 BR BR112014031133-1A patent/BR112014031133B1/pt active IP Right Grant
- 2013-06-13 ES ES13766730.9T patent/ES2664069T3/es active Active
-
2014
- 2014-12-09 IL IL236148A patent/IL236148B/en active IP Right Grant
- 2014-12-11 ZA ZA2014/09124A patent/ZA201409124B/en unknown
- 2014-12-12 TN TN2014000518A patent/TN2014000518A1/fr unknown
-
2016
- 2016-10-03 AU AU2016235036A patent/AU2016235036A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015525076A (ja) | 2015-09-03 |
| US20130337010A1 (en) | 2013-12-19 |
| BR112014031133A2 (https=) | 2017-08-15 |
| WO2013188673A3 (en) | 2014-03-27 |
| MX364875B (es) | 2019-05-09 |
| ZA201409124B (en) | 2017-05-31 |
| KR102136437B1 (ko) | 2020-07-21 |
| IL236148A0 (en) | 2015-01-29 |
| MA37749B1 (fr) | 2017-05-31 |
| WO2013188673A2 (en) | 2013-12-19 |
| MA37749A1 (fr) | 2016-08-31 |
| MX2014015311A (es) | 2016-04-04 |
| US10801039B2 (en) | 2020-10-13 |
| HK1209326A1 (en) | 2016-04-01 |
| BR112014031133B1 (pt) | 2023-02-07 |
| IL236148B (en) | 2019-05-30 |
| JP6347257B2 (ja) | 2018-06-27 |
| CN110628822A (zh) | 2019-12-31 |
| RU2656187C2 (ru) | 2018-05-31 |
| AU2016235036A1 (en) | 2016-10-27 |
| KR20150036057A (ko) | 2015-04-07 |
| RU2015100269A (ru) | 2016-08-10 |
| AU2013274191A1 (en) | 2015-01-22 |
| CA2876196C (en) | 2021-09-21 |
| EP2861248B1 (en) | 2017-11-15 |
| AU2013274191B2 (en) | 2016-09-22 |
| EP2861248A2 (en) | 2015-04-22 |
| NZ703297A (en) | 2016-04-29 |
| CA2876196A1 (en) | 2013-12-19 |
| CN104582724A (zh) | 2015-04-29 |
| ES2664069T3 (es) | 2018-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2014000518A1 (en) | Reassortant btv and ahsv vaccines | |
| MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
| MY202415A (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
| MY181175A (en) | Therapeutic hpv16 vaccines | |
| IL257800A (en) | Immune compositions with improved stability and immunogenicity | |
| TR201908550T4 (tr) | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. | |
| IL248483A0 (en) | Different strains of Listeria recombinant vaccines and methods for their production | |
| PT3207053T (pt) | Novos péptidos imunogénicos | |
| MX2021001053A (es) | Vacunas contra virus de la influenza y sus usos. | |
| MX2018002106A (es) | Vacunas terapeuticas contra el hpv18. | |
| SG195114A1 (en) | Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use | |
| WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| IL251120A0 (en) | Immunogenic/therapeutic glycoside preparations and their uses | |
| MY191539A (en) | Streptococcal vaccine | |
| ZA201608487B (en) | Dual adjuvant vaccine compositions, preparation and uses | |
| IL257194B (en) | Targeted delivery of spray-dried formulations to the lungs | |
| IN2013MU00848A (https=) | ||
| EP3210621A4 (en) | Micellar polypeptide vaccine having pegylated phospholipids as carrier | |
| MX2015015428A (es) | Eliminacion de riesgo de narcolepsia en vacunas contra influenza. | |
| SG10201900598TA (en) | Factor viii formulation | |
| EP3137111A4 (en) | Compositions and methods for intradermal vaccine delivery | |
| ITUB20152497A1 (it) | Treno di compressione di gas di carica di etilene | |
| MX2020002793A (es) | Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados. | |
| PL3077512T3 (pl) | Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego | |
| NZ721832A (en) | Solid forms of tenofovir |